Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.38 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.34 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | HPGD | P15428 | 4/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.31 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.30 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27138722 | 0.81 | HTR3A (0.40) | ADRA1ADYRK1AALDH1A1POLBCHRM4 | |
| SCHEMBL31047840 | 0.80 | KCNJ1 (0.43) | ADRA1ADYRK1AALDH1A1HPGDHSD17B10 | |
| SCHEMBL30988345 | 0.79 | DYRK1A (0.41) | ADRA1ADYRK1AKCNQ3KCNQ2ALDH1A1 | |
| SCHEMBL25644836 | 0.77 | DYRK1A (0.43) | ADRA1ADYRK1AKCNQ3KCNQ2ALDH1A1 | |
| SCHEMBL16824215 | 0.75 | POLB (0.59) | ADRA1ADYRK1AKCNQ3KCNQ2ALDH1A1 | |
| SCHEMBL1133918 | 0.74 | POLB (0.57) | ALDH1A1HSD17B10USP2POLBCYP1A2 | |
| SCHEMBL21292879 | 0.72 | TRIM24 (0.52) | ALDH1A1HSD17B10ALDH3A1ALDH1A3 | |
| SCHEMBL16824217 | 0.72 | ADRA1A (0.44) | ADRA1ADYRK1AKCNQ3KCNQ2ALDH1A1 | |
| SCHEMBL16824313 | 0.71 | ADRA1A (0.48) | ADRA1AKCNQ3KCNQ2ALDH1A1HPGD | |
| SCHEMBL25308181 | 0.71 | TRIM24 (0.44) | ALDH1A1POLBALDH1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113166166-B | Alpha 2-adrenoreceptor subtype C (alpha-2C) antagonists for the treatment of sleep apnea | 拜耳公司 | 2024-09-10 | — | — | CN | claimed |
| CN-113166166-B | Alpha 2-adrenoreceptor subtype C (alpha-2C) antagonists for the treatment of sleep apnea | 拜耳公司 | 2024-09-10 | — | — | CN | disclosed |
| EP-3615031-A1 | SELECTIVE ADRENORECEPTOR ALPHA2C RECEPTOR ANTAGONISTS ALONE, OR IN COMBINATION WITH CHYMASE INHIBITORS FOR USE IN THE TREATMENT AND/OR PROPHYLAXIS OF PERIPHERAL ARTERY DISEASES (PAD) | Bayer Aktiengesellschaft (DE) | 2020-03-04 | — | — | EP | disclosed |
| WO-2018197333-A1 | SELECTIVE ADRENORECEPTOR ALPHA2C RECEPTOR ANTAGONISTS ALONE, OR IN COMBINATION WITH CHYMASE INHIBITORS FOR USE IN THE TREATMENT AND/OR PROPHYLAXIS OF PERIPHERAL ARTERY DISEASES (PAD) | BAYER AKTIENGESELLSCHAFT (DE) | 2018-11-01 | — | — | WO | disclosed |